Gene · 1062
Papers2,042
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 2,042
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Endothelial CD34 expression and regulation of immune cell response in-vitro. | Sci Rep | 2023 | 37598252 | PubTator, text mining | PubMed |
| Primary microcephaly gene CENPE is a novel biomarker and potential therapeutic target for non-WNT/non-SHH medulloblastoma. | Front Immunol | 2023 | 37593739 | PubTator, text mining | PubMed |
| Phosphorylation controls spatial and temporal activities of motor-PRC1 complexes to complete mitosis. | EMBO J | 2023 | 37592895 | PubTator, text mining | PubMed |
| Aberrant activation of five embryonic stem cell-specific genes robustly predicts a high risk of relapse in breast cancers. | BMC Genomics | 2023 | 37592220 | PubTator, text mining | PubMed |
| Genomic alterations as independent prognostic factors to predict the type of lung cancer recurrence. | Gene | 2023 | 37544338 | PubTator, text mining | PubMed |
| A novel metabolic subtype with S100A7 high expression represents poor prognosis and immuno-suppressive tumor microenvironment in bladder cancer. | BMC Cancer | 2023 | 37543645 | PubTator, text mining | PubMed |
| Therapeutic response to pazopanib: case report and literature review on molecular abnormalities of aggressive prolactinomas. | Front Endocrinol (Lausanne) | 2023 | 37529607 | PubTator, text mining | PubMed |
| Identification of an Imidazopyridine-based Compound as an Oral Selective Estrogen Receptor Degrader for Breast Cancer Therapy. | Cancer Res Commun | 2023 | 37520743 | PubTator, text mining | PubMed |
| An unconventional TOG domain is required for CLASP localization. | Curr Biol | 2023 | 37516114 | PubTator, text mining | PubMed |
| Validation of an Ultraviolet Light Response Gene Signature for Predicting Prognosis in Patients with Uveal Melanoma. | Biomolecules | 2023 | 37509183 | PubTator, text mining | PubMed |
| Microtubule nucleation for spindle assembly: one molecule at a time. | Trends Biochem Sci | 2023 | 37482516 | PubTator, text mining | PubMed |
| ATAD2 is a driver and a therapeutic target in ovarian cancer that functions by upregulating CENPE. | Cell Death Dis | 2023 | 37479754 | PubTator, text mining | PubMed |
| Pan-Cancer Analysis Reveals CENPI as a Potential Biomarker and Therapeutic Target in Adrenocortical Carcinoma. | J Inflamm Res | 2023 | 37465344 | PubTator, text mining | PubMed |
| Pan-cancer evaluation of clinical value of mitotic network activity index (MNAI) and its predictive value for immunotherapy. | Front Oncol | 2023 | 37456231 | PubTator, text mining | PubMed |
| High-throughput functional screen identifies YWHAZ as a key regulator of pancreatic cancer metastasis. | Cell Death Dis | 2023 | 37452033 | PubTator, text mining | PubMed |
| 3D Ultrastructural Visualization of Mitosis Fidelity in Human Cells Using Serial Block Face Scanning Electron Microscopy (SBF-SEM). | Bio Protoc | 2023 | 37449034 | PubTator, text mining | PubMed |
| Comparative Analysis of Water Extracts from Roselle (Hibiscus sabdariffa L.) Plants and Callus Cells: Constituents, Effects on Human Skin Cells, and Transcriptome Profiles. | Int J Mol Sci | 2023 | 37446030 | PubTator, text mining | PubMed |
| Target and Mechanism of the Xihuang Pill Based on Network Pharmacology for Lung Squamous Cell Carcinoma. | Altern Ther Health Med | 2023 | 37442189 | PubTator, text mining | PubMed |
| Psoriasis Associated Hub Genes Revealed by Weighted Gene Co-Expression Network Analysis. | Cell J | 2023 | 37434459 | PubTator, text mining | PubMed |
| Downregulation of Microcephaly-Causing Genes as a Mechanism for ZIKV Teratogenesis: A Meta-analysis of RNA-Seq Studies. | J Mol Neurosci | 2023 | 37428363 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1062/papers?page=8